(Q50525832)

14 March 2018

title

Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience. (English)

1 reference

14 March 2018

congenital cytomegalovirus infection

main subject

Cytomegalovirus

0 references

1 reference

Nigro G

1

1 reference

14 March 2018

Scholz H

series ordinal

2

1 reference

14 March 2018

Bartmann U

series ordinal

3

1 reference

14 March 2018

language of work or name

English

0 references

publication date

1 February 1994

1 reference

14 March 2018

The Journal of Pediatrics

published in

1 reference

14 March 2018

volume

124

1 reference

14 March 2018

page(s)

318-322

1 reference

14 March 2018

issue

2

1 reference

14 March 2018

Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

Sequelae of acquired cytomegalovirus infection in premature and sick term infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

Early clinical manifestations and intellectual outcome in children with symptomatic congenital cytomegalovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

Cytomegalovirus and child day care. Evidence for an increased infection rate among day-care workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

Cytomegalovirus Infection in Patients with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

Ganciclovir therapy of congenital cytomegalovirus pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

Fatal congenital cytomegalovirus infection acquired by an intra-uterine transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

Ganciclovir therapy of congenital cytomegalovirus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

Cytomegalovirus infection: a pediatrician's perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

Treatment of cytomegalovirus enterocolitis with ganciclovir in an infant with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

Ganciclovir treatment of cytomegalovirus disease in immunocompromised children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

Cytomegalovirus encephalitis and ganciclovir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

Inhibitory effects of urine on the polymerase chain reaction for cytomegalovirus DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

Noncirrhotic portal fibrosis following neonatal cytomegalic inclusion disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

Group day care and cytomegaloviral infections of mothers and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

7 January 2021

Cytomegalovirus transmission among children in day care, their mothers and caretakers

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

7 January 2021

Hepatitis in pre-school children: prevalent role of cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

7 January 2021

Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

7 January 2021

Diffuse hepatic fibrosis in congenital cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970327-2

7 January 2021

10.1016/S0022-3476(94)70327-2

Identifiers

DOI

1 reference

14 March 2018

PubMed ID

8301446

1 reference

14 March 2018